An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...
News-Medical.Net on MSN
Experimental drug targets early toxic amyloid to slow Alzheimer’s disease
An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...
New research, published in Nature, has provided the first ever population-based data on the frequency of Alzheimer's disease ...
A small study shows cognitive improvements in patients with AD following treatment with an in-home gamma sensory stimulation ...
A study of blood-based markers for Alzheimer’s disease in Norway confirms earlier estimates, and may show how education level ...
Research published in the Journal of Alzheimer's Disease suggests findings could transform emergency protocols for the 2.5 ...
Blood tests for Alzheimer’s disease are becoming more accurate, but researchers stress the need for caution and further study.
A pioneering study indicates that Alzheimer’s disease is considerably more widespread among individuals over 85 than ...
One of the main proteins that contributes to Alzheimer's disease is called phospho-tau (p-tau). When p-tau gets too many ...
People who regularly ate higher-fat cheese and cream had a lower risk of dementia over 25 years, while low-fat dairy and ...
New Alzheimer's drug Leqembi offers hope to Oklahoma couple as they celebrate 50 years of marriage and fight against the ...
A new study presents robust evidence on the role of lysophosphatidylcholines (LPCs) in the onset of Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results